EPI Gains $150K NCI Grant for Breast Cancer Biomarker Dx | GenomeWeb
NEW YORK (GenomeWeb News) – Expression Pathology plans to use a $148,000 grant from the National Cancer Institute to identify biomarkers and develop breast cancer diagnostic technology, the company said today.
 
Gaithersburg, Md.-based EPI said it will use the Small Business Innovation Research grant to use its microproteomics technologies to identify protein biomarkers of metastasis in primary breast cancer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.